EyePoint Pharmaceuticals (EYPT) EPS (Weighted Average and Diluted): 2011-2016
Historic EPS (Weighted Average and Diluted) for EyePoint Pharmaceuticals (EYPT) over the last 2 years, with Jun 2016 value amounting to -$0.19.
- EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) fell 11.76% to -$0.19 in Q2 2016 from the same period last year, while for Jun 2016 it was -$0.69, marking a year-over-year decrease of 463.16%. This contributed to the annual value of -$0.52 for FY2017, which is 23.53% up from last year.
- As of Q2 2016, EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.19, which was down 26.67% from -$0.15 recorded in Q1 2016.
- EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.67 during Q3 2014, with a 5-year trough of -$0.19 in Q2 2016.
- For the 3-year period, EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.07, with its median value being -$0.16 (2015).
- Per our database at Business Quant, EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 1,414.53% in 2012 and then spiked by 578.57% in 2014.
- EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.11 in 2012, then reached -$0.13 in 2013, then declined by 7.69% to -$0.14 in 2014, then decreased by 28.57% to -$0.18 in 2015, then decreased by 11.76% to -$0.19 in 2016.
- Its last three reported values are -$0.19 in Q2 2016, -$0.15 for Q1 2016, and -$0.18 during Q4 2015.